These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14871103)

  • 1. Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2.
    Shamis M; Lode HN; Shabat D
    J Am Chem Soc; 2004 Feb; 126(6):1726-31. PubMed ID: 14871103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry.
    Gopin A; Ebner S; Attali B; Shabat D
    Bioconjug Chem; 2006; 17(6):1432-40. PubMed ID: 17105221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier.
    Sagi A; Segal E; Satchi-Fainaro R; Shabat D
    Bioorg Med Chem; 2007 Jun; 15(11):3720-7. PubMed ID: 17416532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic activation of hydrophobic self-immolative dendrimers: the effect of reporters with ionizable functional groups.
    Avital-Shmilovici M; Shabat D
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3959-62. PubMed ID: 19303773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of self-immolative linkers for tumour-activated prodrug therapy.
    Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
    Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity.
    Shamis M; Barbas CF; Shabat D
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of carbamate-based 20(S)-camptothecin prodrugs.
    Pessah N; Reznik M; Shamis M; Yantiri F; Xin H; Bowdish K; Shomron N; Ast G; Shabat D
    Bioorg Med Chem; 2004 Apr; 12(8):1859-66. PubMed ID: 15051055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger.
    Gopin A; Pessah N; Shamis M; Rader C; Shabat D
    Angew Chem Int Ed Engl; 2003 Jan; 42(3):327-32. PubMed ID: 12548691
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.
    Shabat D; Lode HN; Pertl U; Reisfeld RA; Rader C; Lerner RA; Barbas CF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7528-33. PubMed ID: 11404472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldolase antibody activation of prodrugs of potent aldehyde-containing cytotoxics for selective chemotherapy.
    Sinha SC; Li LS; Watanabe S; Kaltgrad E; Tanaka F; Rader C; Lerner RA; Barbas CF
    Chemistry; 2004 Oct; 10(21):5467-72. PubMed ID: 15378729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation.
    Abraham S; Guo F; Li LS; Rader C; Liu C; Barbas CF; Lerner RA; Sinha SC
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5584-9. PubMed ID: 17372220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receiver-amplifier, self-immolative dendritic device.
    Amir RJ; Danieli E; Shabat D
    Chemistry; 2007; 13(3):812-21. PubMed ID: 17075925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
    Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
    Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-immolative anthracycline prodrugs for suicide gene therapy.
    Niculescu-Duvaz I; Niculescu-Duvaz D; Friedlos F; Spooner R; Martin J; Marais R; Springer CJ
    J Med Chem; 1999 Jul; 42(13):2485-9. PubMed ID: 10395490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of a catalytic antibody-HPMA copolymer-Conjugate as a tool for tumor selective prodrug activation.
    Satchi-Fainaro R; Wrasidlo W; Lode HN; Shabat D
    Bioorg Med Chem; 2002 Sep; 10(9):3023-9. PubMed ID: 12110325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of self-immolative dendrimers for drug delivery and sensing.
    Wang RE; Costanza F; Niu Y; Wu H; Hu Y; Hang W; Sun Y; Cai J
    J Control Release; 2012 Apr; 159(2):154-63. PubMed ID: 22155555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A doxorubicin prodrug activated by the staudinger reaction.
    van Brakel R; Vulders RC; Bokdam RJ; Grüll H; Robillard MS
    Bioconjug Chem; 2008 Mar; 19(3):714-8. PubMed ID: 18271515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.